Introduction
============

Ketoconazole is an antifungal drug approved by the US FDA in 1981. Only a few analytical methods for the determination of the drug in biological samples and in the presence of other drugs have been reported \[[@b1-scipharm-2011-79-817]--[@b12-scipharm-2011-79-817]\]. The photodegradation behavior of Ketoconazole has been reported by Staub et al \[[@b13-scipharm-2011-79-817]\]. The drug substance is official in Ph. Eur. but the specified impurities are not mentioned. The present study deals with understanding the degradation behavior of Ketoconazole by subjecting it to acid, base, aqueous, thermal, photo and oxidative stress conditions. Furthermore, the two major degradation impurities observed under stressed condition were identified by LC-MS techniques, elemental analysis, NMR, and their structures were justified through mechanistic explanation.

Experimental
============

Material and reagents
---------------------

Ketoconazole drug substance was obtained from Sharon Biomedichem (Navi Mumbai, India). All the chemicals and reagents, hydrochloric acid, sodium hydroxide, hydrogen peroxide (30 %), tetrabutylammonium hydrogen sulphate, acetonitrile and methanol were used of analytical grade, while a millipore milli Q plus water purification system (Milford, USA) was used to prepare distilled water (\>18 μΩ).

Instruments
-----------

Integrated HPLC system, Ultimate 3000 manufactured by Dionex (Germany) was used for method development and method validation. This system consisted of a quaternary gradient pump, auto sampler, column oven and a photodiode array detector. PC installed Chromeleon software was used to record and to integrate the chromatograms. The analysis was carried out at ambient temperature. LCMS system, Agilent ion trap 6310 was used for mass fragmentation analysis. NMR experiments were recorded on Bruker 500 Mz spectrometer. Photostability studies were performed in a photostability chamber from Thermolab (India).

Chromatographic conditions
--------------------------

### Analytical HPLC conditions

Inertsil ODS (Length: 100 mm, Diameter: 4.6 mm, Particle size: 3 μm) analytical column was used as a stationary phase. The flow rate was 2.0 ml min^−1^ and the detector was set at 220 nm. The volume of the sample solution injected was 10 μl. The gradient mobile phase consisted of Mobile phase A {(Acetonitrile: 3.4 g/l solution of tetrabutylammonium hydrogen sulphate (5:95 V/V)}: and Mobile phase B {(Acetonitrile: 3.4 g/l solution of tetra-butylammonium hydrogen sulphate (50:50 V/V)}. A membrane filter of 0.45 μm porosity was used to filter and degas the mobile phase. (Gradient program as mentioned in [Tab. 1](#t1-scipharm-2011-79-817){ref-type="table"}).

### Analytical LC--MS conditions

Inertsil ODS (Length: 100 mm, Diameter: 4.6 mm, Particle size: 3 μm) analytical column was used as a stationary phase. The flow rate was 2.0 ml min^−1^ and the detector was set at 220 nm. The volume of the sample solution injected was 10 μL. The gradient mobile phase consisted of Mobile phase A (Water) and Mobile phase B (Acetonitrile). A membrane filter of 0.45 μm porosity was used to filter and degas the mobile phase. The gradient program as mentioned in [Table 2](#t2-scipharm-2011-79-817){ref-type="table"}. The LC-Mass condition was set using Nebulizer 50 PSI, dry gas temperature 350 degree and source ESI positive.

Stress degradation of drug substance
------------------------------------

Stress studies were carried out under acid, base, thermal, photo and oxidative stress conditions.

### Acid Hydrolysis

250.0 mg of test sample + 2ml 1N HCl into 25 ml volumetric flask. Sample heated on boiling water bath at 100 deg, withdrawn at 2 min and 8 min, respectively, then neutralized with 1N NaOH solution and make up the volume to 25 ml with methanol. Pipette out 4 ml into 50 ml volumetric flask and dilute to volume with methanol.

One unknown degradation impurity was observed under acidic condition ([Table 3](#t3-scipharm-2011-79-817){ref-type="table"} and [figure 1c](#f1-scipharm-2011-79-817){ref-type="fig"}). In [figure 1c](#f1-scipharm-2011-79-817){ref-type="fig"}, the main degradation product is unknown impurity at RRT 0.80.

### Base Hydrolysis

250.0 mg of test sample + 2ml 1N NaOH into 25 ml volumetric flask. Sample heated on boiling water bath for 10 min and 30 min, respectively, then neutralized with 1N HCl solution and make up the volume to 25 ml with methanol. Pipette out 4 ml into 50 ml volumetric flask and dilute to volume with methanol.

One unknown degradation impurity was observed under basic condition which is the same as observed under acidic condition ([Table 4](#t4-scipharm-2011-79-817){ref-type="table"} and [figure 1d](#f1-scipharm-2011-79-817){ref-type="fig"}). In [figure 1d](#f1-scipharm-2011-79-817){ref-type="fig"}, the main degradation product is unknown impurity at 0.80.

### Oxidation

250.0 mg of test sample + 2ml 30%H2O2 into 25 ml volumetric flask and heated for 10 min on boiling water bath. Make up the volume to 25 ml with methanol. Pipette out 4 ml into 50 ml volumetric flask and dilute to volume with methanol.

One unknown degradation impurity was observed under oxidative stress condition and it is different from the impurity observed under acidic/basic condition ([Table 5](#t5-scipharm-2011-79-817){ref-type="table"} and [figure 1e](#f1-scipharm-2011-79-817){ref-type="fig"}). In [figure 1.e](#f1-scipharm-2011-79-817){ref-type="fig"}, the main degradation product is unknown impurity at RRT 0.72.

### Thermal

Test sample of Ketoconazole was subjected to thermal degradation by exposure to oven at 105°C for 24h and 60°C at 5 days and 10 days. 250.0 mg test sample of Ketoconazole were dissolved and diluted with methanol to 25 ml. Pipette out 4 ml into 50 ml volumetric flask and dilute to volume with methanol.

### Photolysis

About 250.0 mg test sample of Ketoconazole is kept for UV degradation for 24hours at 254 nm wavelength and then dissolved and diluted with methanol to 25 ml. Pipette out 4 ml into 50 ml volumetric flask and dilute to volume with methanol. The drug substance was found stable under photo and thermal stress conditions as shown in below ([Table 6](#t6-scipharm-2011-79-817){ref-type="table"}, [figure 1f and 1g](#f1-scipharm-2011-79-817){ref-type="fig"}).

Preparation of Impurities
=========================

Hydrolysis degradent, Impurity D as per Ph. Eur., is synthesized in-house and identified by HPLC analysis, Mass spectrometer ([figure 3b](#f3-scipharm-2011-79-817){ref-type="fig"}) and elemental analysis ([figure 6b](#f6-scipharm-2011-79-817){ref-type="fig"}). Oxidative degradent is prepared in-house by degradation of Ketoconazole with 30% hydrogen peroxide by heating up to evaporate to dryness at 80**°**C. Ketoconazole gets converted to its N-oxide and identified by HPLC ([figure 2b](#f2-scipharm-2011-79-817){ref-type="fig"}), LCMS analysis ([figure 3c](#f3-scipharm-2011-79-817){ref-type="fig"}), NMR analysis ([figure 5b](#f5-scipharm-2011-79-817){ref-type="fig"}) and Elemental analysis ([figure 6c, 6d](#f6-scipharm-2011-79-817){ref-type="fig"}).

Elemental analysis
==================

Elemental analysis (CHNO) of Ketoconazole, Hydrolysis degradent and Oxidative degradent performed and results shown below [Table 7](#t7-scipharm-2011-79-817){ref-type="table"} and [8](#t8-scipharm-2011-79-817){ref-type="table"}.

NMR analysis
============

NMR analysis of Ketoconazole and the oxidative degradent were performed and the results are shown in [Table 9](#t9-scipharm-2011-79-817){ref-type="table"}.

Results and discussion
======================

The degradation of Ketoconazole was performed under different stress conditions. Two major degradants are observed under stress degradation. One is hydrolysis product of Ketoconazole observed under acid/base condition and the other one is oxidative degradent observed under oxidative stress condition. The identification of oxidative degradent was achieved by LC-MS, NMR and Elemental analysis. The LC-MS data shows the mass 547.43 amu which exactly increase in the mass 16 amu from the Ketoconazole drug substance having mass 531.43 amu, which indicate the formation of N-oxide. LC-MS spectrums and fragmentation behavior of N-Oxide are given in [figure 3c](#f3-scipharm-2011-79-817){ref-type="fig"} and [4b](#f4-scipharm-2011-79-817){ref-type="fig"}. Also, the elemental analysis of N-oxide shows the increase in oxygen atom ([figure 6d](#f6-scipharm-2011-79-817){ref-type="fig"}), while in the case of hydrolysis decrease in oxygen atom compare to Ketoconazole. The NMR analysis of oxidative degradent shows the shifting of protons signal from their original position in Ketoconazole due to introduction electronegative oxygen atom ([figure 5b](#f5-scipharm-2011-79-817){ref-type="fig"}).

Hence, the formation of the oxidative degradation product from the drug as shown below is only due to the N-oxide formation at the piperazine ring. The lone pair at the nitrogen of the piperazine ring is more prone for oxidation to form an N-oxide. However, out of two nitrogen atoms, the electron pair on the nitrogen attached to the carbonyl group is participating in resonance delocalization with this group. Hence, the most possible N-Oxide at the nitrogen is at the one attached to the phenolic group ([scheme 1](#f7-scipharm-2011-79-817){ref-type="fig"}).

Similar types of N-oxide degradents have been reported in the literature \[[@b14-scipharm-2011-79-817]--[@b16-scipharm-2011-79-817]\].

Conclusions
===========

The Stress degradation on Ketoconazole was carried out under different acid, base, thermal, photo and oxidative stress conditions. The drug was found susceptible to acid, base and oxidative stress degradation. The unknown degradation products formed in the oxidative and hydrolysis stressed sample were identified using LC--MS and elemental analysis (CHNO). The investigations of oxidative and hydrolysis degradent will help to take proper care during selection of excipients in formulation, storage, packaging and handling of the drug product.
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HPLC Chromatograms for Stressed conditions
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![HPLC Chromatograms for preparation Oxidative degradent](scipharm-2011-79-817f2){#f2-scipharm-2011-79-817}

###### 

LC-Mass spectrum for Ketoconazole and degradent products
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###### 

Mobile Phase gradient for HPLC chromatographic method

  Time (min)   Mobile phase A (% V/V)   Mobile phase B (& V/V)
  ------------ ------------------------ ------------------------
  0            100                      0
  10           0                        100
  15           0                        100
  17           100                      0
  20           100                      0

###### 

Mobile Phase gradient for LC-MS method

  Time (min)   Water (% V/V)   Acetonitrile (% V/V)
  ------------ --------------- ----------------------
  0            100             0
  20           0               100
  30           0               100

###### 

Results of Acid degradation (1M HCl)

  Name of compounds   RRT      Sample "as such"   Initial   4 hours at 25°C   2 minutes heating at 100°C   8 minutes heating at 100°C
  ------------------- -------- ------------------ --------- ----------------- ---------------------------- ----------------------------
  Unknown             \~0.66   ND                 ND        0.052             ND                           0.085
  Unknown             \~0.72   ND                 ND        0.105             0.042                        0.080
  Unknown             \~0.76   ND                 ND        ND                0.036                        ND
  Unknown             \~0.80   0.005              0.018     0.878             5.778                        22.122
  Ketoconazole        \~1.00   99.535             99.510    98.213            91.417                       69.620
  Unknown             \~1.03   0.049              0.054     0.050             0.085                        0.046
  Unknown             \~1.09   ND                 ND        ND                0.045                        ND
  Unknown             \~1.11   ND                 ND        0.017             0.046                        0.085
  Unknown             \~1.19   0.196              0.200     0.206             0.220                        0.110
  Unknown             \~1.32   0.104              0.102     0.009             0.139                        ND
  Unknown             \~1.38   0.114              0.110     0.106             0.126                        ND

###### 

Results of Base degradation (1M NaOH)

  Name of compounds   RRT      Sample "as such"   Initial   4 hours at 25°C   10 minutes heating at 100°C   30 minutes heating at 100°C
  ------------------- -------- ------------------ --------- ----------------- ----------------------------- -----------------------------
  Unknown             \~0.66   ND                 0.083     0.124             0.088                         ND
  Unknown             \~0.72   ND                 0.091     0.137             0.090                         0.023
  Unknown             \~0.80   0.005              0.010     0.439             5.328                         10.702
  Ketoconazole        \~1.00   99.535             99.310    98.055            92.172                        88.821
  Unknown             \~1.03   0.049              0.076     0.136             0.079                         0.109
  Unknown             \~1.09   ND                 ND        ND                ND                            ND
  Unknown             \~1.11   ND                 0.014     0.004             0.161                         0.163
  Unknown             \~1.19   0.196              0.200     0.212             0.100                         0.037
  Unknown             \~1.32   0.104              0.099     0.114             0.094                         0.130
  Unknown             \~1.38   0.114              0.111     0.120             ND                            ND

###### 

Results of Oxidative degradation (30% H~2~O~2~)

  Name of compounds   RRT      Sample "as such"   Initial   4 hours at 25°C   10 minutes heating at 100°C
  ------------------- -------- ------------------ --------- ----------------- -----------------------------
  Unknown             \~0.54   ND                 ND        ND                0.219
  Unknown             \~0.56   ND                 ND        ND                0.134
  Unknown             \~0.66   ND                 0.125     0.149             0.084
  Unknown             \~0.72   ND                 0.172     0.860             23.528
  Unknown             \~0.80   0.005              0.007     0.008             0.078
  Ketoconazole        \~1.00   99.535             99.185    98.478            74.995
  Unknown             \~1.03   0.049              0.124     0.116             0.500
  Unknown             \~1.19   0.196              0.213     0.212             0.174
  Unknown             \~1.32   0.104              0.012     0.010             0.047
  Unknown             \~1.38   0.114              0.124     0.124             0.122

###### 

Results of Thermal and UV degradation

  Name of compound   RRT      Sample "as such"   105°C at 24 hours   60°C at 5 days   60°C at 10 days   24 hours at 254 nm
  ------------------ -------- ------------------ ------------------- ---------------- ----------------- --------------------
  Unknown            \~0.80   0.005              0.008               0.008            0.007             0.007
  Ketoconazole       \~1.00   99.535             99.576              99.578           99.561            99.536
  Unknown            \~1.03   0.049              0.046               0.050            0.055             0.053
  Unknown            \~1.19   0.196              0.179               0.183            0.190             0.195
  Unknown            \~1.32   0.104              0.103               0.093            0.102             0.097
  Unknown            \~1.38   0.114              0.085               0.084            0.083             0.109

###### 

Results of Elemental analysis

      Ketoconazole MW 531.43   Hydrolysis degradent MW 488.9   Oxidative degradent MW 547.43                    
  --- ------------------------ ------------------------------- ------------------------------- ------- -------- --------
  C   58.71                    58.87                           58.91                           58.84   56.994   58.378
  H   5.27                     5.38                            5.32                            5.35    5.115    5.254
  N   10.54                    10.55                           11.45                           10.62   10.230   10.092
  O   12.04                    12.03                           9.82                            10.03   14.614   14.066

###### 

No of atoms present in molecule

  Element                      Ketoconazole              Hydrolysis degradent      Oxidative degradent
  ---------------------------- ------------------------- ------------------------- -------------------------
  C                            26                        24                        26
  H                            28                        26                        28
  N                            4                         4                         4
  O                            4                         3                         5
  Observed Molecular formula   C~26~H~28~Cl~2~N~4~O~4~   C~24~H~26~Cl~2~N~4~O~3~   C~26~H~28~Cl~2~N~4~O~5~

###### 

Results of NMR analysis

                           Ketoconazole   Oxidative degradent                  
  ------------------------ -------------- --------------------- -------------- --------
  1 CH~3~ group            2.134          2.939                 2.103, 1.881   3.237
  7 CH~2~ and 1 CH group   2.988--3.897   15.075                3.200--4.794   15.525
  Aromatic protons         6.777--7.660   9.757                 6.826--7.841   9.796
